Use of direct-acting antiviral (DAA) treatment (without interferon) was shown to reduce liver and nonliver complications, as well as improve long-term overall survival among patients with chronic ...

Direct-acting antiviral therapy has reduced the prevalence of hepatitis C viremia over time among adults with HIV infection in the United States. The prevalence of hepatitis C virus (HCV) has ...